Back
Apellis Pharmaceuticals Vs. IDT Industry Stock Comparison
Buy
59
APLS
Apellis Pharmaceuticals
Last Price:
$24.38
Seasonality Move:
6.92%
Buy
54
IDT
IDT
Last Price:
$60.29
Seasonality Move:
-0.21%
Buy
59
Apellis Pharmaceuticals (APLS)
is a Buy
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
-
The current Apellis Pharmaceuticals [APLS] share price is $24.37. The Score for APLS is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $24.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.
IDT Stock Price Chart
APLS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.43 | Buy |
Relative Strength Index (14 RSI): | 73.16 | Buy |
Chaikin Money Flow: | 401251 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.44 - 22.66) | Buy |
Bollinger Bands (100): | (17.26 - 21.84) | Buy |
IDT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 16.6 | Buy |
Relative Strength Index (14 RSI): | 51.74 | Buy |
Chaikin Money Flow: | -81972 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (56.43 - 62.39) | Buy |
Bollinger Bands (100): | (51.08 - 64.14) | Buy |
APLS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.15 | Buy |
20-day SMA: | 21.01 | Buy |
50-day SMA: | 19.45 | Buy |
200-day SMA: | 24.57 | Sell |
8-day EMA: | 23.18 | Buy |
20-day EMA: | 21.52 | Buy |
50-day EMA: | 20.25 | Buy |
200-day EMA: | 24.97 | Sell |
IDT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 59.24 | Buy |
20-day SMA: | 58.18 | Buy |
50-day SMA: | 62.39 | Sell |
200-day SMA: | 53.09 | Buy |
8-day EMA: | 53.37 | Buy |
20-day EMA: | 35.2 | Buy |
50-day EMA: | 17.89 | Buy |
200-day EMA: | 5.09 | Buy |
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.08 per share, a decrease next quarter of $1.11 per share, an increase this year of $1.21 per share, and a decrease next year of $0.63 per share.
IDT Earnings Growth & IDT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Apellis Pharmaceuticals Technical Analysis
Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IDT Technical Analysis
Jul 28 | Jul 29 | Jul 30 | Jul 31 | Aug 1 | Aug 4 | Aug 5 | Aug 6 | Aug 7 | Aug 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | Aug | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |